← Back to Clinical Trials
Recruiting NCT07115186

NCT07115186 School-Based Intervention to Enhance Resilience and Stress Coping in Rural Chinese Adolescents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07115186
Status Recruiting
Phase
Sponsor Peking University
Condition Stress, Emotional
Study Type INTERVENTIONAL
Enrollment 850 participants
Start Date 2025-05-12
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Psychoeducationguided written therapywait-list condition

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 850 participants in total. It began in 2025-05-12 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effectiveness of school-based psychological interventions in improving stress resilience and coping skills among adolescents in rural China. The intervention seeks to reduce stress-related mental health symptoms, including depression, anxiety, and post-traumatic stress, measured using validated instruments such as the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder 7-item scale (GAD-7), and the Child PTSD Symptom Scale for DSM-5 (CPSS-5). (See Appendix for full scale descriptions.) Participants will be recruited from rural middle schools and randomly assigned to either an intervention group or a wait-list control group. The intervention consists of four sessions delivered over one week. Assessments will be conducted at baseline, immediately after the intervention, and again at a 3-month and 6-month follow-ups. Researchers will use multilevel modeling (MLM) and structural equation modeling (SEM) to examine potential mediators and moderators of intervention effects, including emotion recognition, alexithymia, and coping strategies. indings are expected to provide evidence on the effectiveness and mechanisms of an existing, school-based psychological intervention tailored to the needs of adolescents in underserved rural settings.

Eligibility Criteria

Inclusion Criteria: * Currently enrolled middle school students attending regular school classes * Sufficient functional capacity in hearing, speaking, reading, and writing to participate in intervention activities and assessments. Exclusion Criteria: * Individuals assessed to be at high risk of suicide, based on screening or clinical judgment * Diagnosis of severe mental disorders (e.g., psychotic disorders, severe mood disorders) that would interfere with participation or require more intensive clinical care

Contact & Investigator

Central Contact

Zang Yinyin, PhD

✉ yinyin.zang@pku.edu.cn

📞 +86 15553201610

Frequently Asked Questions

Who can join the NCT07115186 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Stress, Emotional. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07115186 currently recruiting?

Yes, NCT07115186 is actively recruiting participants. Contact the research team at yinyin.zang@pku.edu.cn for enrollment information.

Where is the NCT07115186 trial being conducted?

This trial is being conducted at Hebei, China.

Who is sponsoring the NCT07115186 clinical trial?

NCT07115186 is sponsored by Peking University. The trial plans to enroll 850 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology